Silgan Unicep

Medical device contract manufacturer · Sandpoint, Idaho, United States

Silgan Unicep is a medical device contract manufacturer with a registered site in Sandpoint, Idaho, United States. The US FDA lists 2 medical device sites and 2 drug manufacturing or testing sites registered to the company, with devices in dental, general and plastic surgery and neurology.

Profile compiled from public records. Is this your company? Request a correction or update

Silgan Unicep at a glance

Typemedical device contract manufacturer
Registered siteSandpoint, Idaho, United States
FDA-registered sites4

What does Silgan Unicep do?

Medical specialties of its FDA-listed devices

DentalGeneral and Plastic SurgeryNeurologyHematologyRadiology

Device types listed with the FDA

Dermal cooling pack/vacuum/massagerMedia, electroconductiveTeeth, porcelainStains, dye solutionCleanser, root canalDevice, caries detectionVarnish, cavitySystem, x-ray, film marking, radiographic

Operations at its FDA-registered drug sites

LabelingManufacturingPacking

Where is Silgan Unicep located?

Registered site: Sandpoint, Idaho, United States

  • Sandpoint, IdahoSilgan Unicep Packaging, LLC. · FDA device and drug site
  • Spokane, WashingtonSilgan Unicep Packaging, LLC. · FDA device and drug site

Frequently asked questions about Silgan Unicep

Where is Silgan Unicep based?

Silgan Unicep is based in Sandpoint, Idaho, United States.

What does Silgan Unicep do?

Silgan Unicep is a medical device contract manufacturer. Its FDA-listed medical devices fall under dental, general and plastic surgery and neurology. Its FDA-registered drug sites are registered for labeling, manufacturing and packing.

How many FDA-registered sites does Silgan Unicep have?

The US FDA lists 4 registered sites for Silgan Unicep.

Similar companies

Work with CROs and CDMOs like Silgan Unicep

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

List your services on BioBridgeX

Last updated 2026-09-23. Data licences